IMPACT® Peptide 1.5, 8.45 Fluid Ounce, 24 Per Case

IMPACT® Peptide 1.5 is a peptide-based immunonutrition formula designed to promote tolerance in surgery and trauma patients. This specialized beverage contains a proven blend of arginine, fish oil, and nucleotides supported by over 40 published randomized controlled trials and numerous real-world evidence studies. The unique studied blend of L-arginine, omega-3 fatty acids, and nucleotides supports the immune system and helps reduce rates of infection, length of stay, and ventilator days in surgical and critically ill patients. Hydrolyzed protein and 50% of fat as medium-chain triglycerides (MCT) helps facilitate absorption to support formula tolerance. The formula is high in protein and supplemented with L-arginine, zinc, and other antioxidants to support wound management.

Uses

• Perioperative Nutrition: Designed for use as early enteral nutrition to support immune function in surgical and critically ill patients.
• Major Cancer Surgery: Found to be most efficacious for use in major cancer surgery cases.
• Wound Management: High protein content combined with antioxidants and zinc helps support wound healing processes.

Product Highlights

• Immunonutrient Blend: Contains a unique studied blend of L-arginine, omega-3 fatty acids, and nucleotides.
• Protein & Fat Composition: Features hydrolyzed protein and 50% of fat as MCT to facilitate absorption.
• Clinical Support: Supported by the Critical Care Nutrition Guidelines for perioperative use.
• Format: Available in 8.45 fluid ounce containers, with 24 containers per case.

Good Fit For

• Hospitals & Clinical Settings: Suitable for facilities requiring specialized enteral nutrition for trauma and surgical recovery.
• Medical Supply Distributors: Ideal for suppliers serving healthcare professionals and specialty diet channels.

Use Case Notes

• Peptide-Based Formula: Specifically formulated to promote tolerance in patients with compromised digestive function.
• Cost Efficiency: Retrospective studies have shown an association with lower adjusted mean hospital cost per day compared to lower arginine immunonutrition or standard high-protein formulas.